Gisèle Clofent-Sanchez

Dr. Gisèle Clofent-Sanchez


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
MJMarie-Josée Jacobin-Valat
Marie-Josée Jacobin-Valat
JLJeanny Laroche-Traineau
Jeanny Laroche-Traineau
MLMélusine Larivière
Mélusine Larivière
SMStéphane Mornet
Stéphane Mornet
SSStéphane Sanchez
Stéphane Sanchez
GCGisèle Clofent-Sanchez
Gisèle Clofent-Sanchez

20 December 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
AHAudrey Hemadou
Audrey Hemadou
VGVéronique Giudicelli
Véronique Giudicelli
MSMelissa Laird Smith
Melissa Laird Smith
Marie-Paule LefrancMarie-Paule Lefranc
Marie-Paule Lefranc
PDPatrice Duroux
Patrice Duroux
GCGisèle Clofent-Sanchez
Gisèle Clofent-Sanchez
Phage-display selection of immunoglobulin (IG) or antibody single chain Fragment variable (scFv) from combinatorial libraries is widely used for identifying new antibodies for novel targets. Next-generation sequencing (NGS) has recently emerged as a new method for the high throughput characterization of IG and T cell receptor (TR) immune repertoires both in vivo and in vitro. However, challenges remain for the NGS sequencing of scFv from combinatorial libraries owing to the scFv length (>800 bp) and the presence of two variable domains [variable heavy (VH) and variable light (VL) for IG] associated by a peptide linker in a single chain. Here, we show that single-molecule real-time (SMRT) sequencing with the Pacific Biosciences RS II platform allows for the generation of full-length scFv reads obtained from an in vivo selection of scFv-phages in an animal model of atherosclerosis. We first amplified the DNA of the phagemid inserts from scFv-phages eluted from an aortic section at the third round of the in vivo selection. From this amplified DNA, 450,558 reads were obtained from 15 SMRT cells. Highly accurate circular consensus sequences from these reads were generated, filtered by quality and then analyzed by IMGT/HighV-QUEST with the functionality for scFv. Full-length scFv were identified and characterized in 348,659 reads. Full-length scFv sequencing is an absolute requirement for analyzing the associated VH and VL domains enriched during the in vivo panning rounds. In order to further validate the ability of SMRT sequencing to provide high quality, full-length scFv sequences, we tracked the reads of an scFv-phage clone P3 previously identified by biological assays and Sanger sequencing. Sixty P3 reads showed 100% identity with the full-length scFv of 767 bp, 53 of them covering the whole insert of 977 bp, which encompassed the primer sequences. The remaining seven reads were identical over a shortened length of 939 bp that excludes the vicinity of primers at both ends. Interestingly these reads were obtained from each of the 15 SMRT cells. Thus, the SMRT sequencing method and the IMGT/HighV-QUEST functionality for scFv provides a straightforward protocol for characterization of full-length scFv from combinatorial phage libraries.

1 September 2017 in International Journal of Cardiology
Verified
Journal Article
Open access
LPLine Pourtau
Line Pourtau
JSJean Marc Sellal
Jean Marc Sellal
RLRomaric Lacroix
Romaric Lacroix
PPPhilippe Poncelet
Philippe Poncelet
OBOlivier Bernus
Olivier Bernus
PNPaquita Nurden
Paquita Nurden
Thrombotic risk constitutes a major complication of atrial fibrillation (AF). Platelets and microparticles (MPs) are important for hemostasis and thrombosis, however their participation during AF is not well known. The aim of this study was to characterize platelet function and MPs procoagulant and fibrinolytic activity in AF patients and to determine the effects of an acute-AF episode. Blood was collected from paroxysmal (21) and persistent (16) AF patients referred for AF catheter ablation. Ten patients in sinus rhythm for 10days were induced in AF allowing comparisons of left atrium samples before and after induction. Platelet aggregation with ADP, TRAP, collagen, and ristocetin was studied. Platelet surface expression of PAR-1, αIIbβ3, GPIb and P-selectin were evaluated by flow cytometry, and MPs-associated procoagulant and fibrinolytic activity levels were determined by functional assays. A specific reduction in platelet aggregation to TRAP, activating the thrombin receptor PAR-1, was found in all AF patients. No differences in platelet receptor expression were found. Yet, after acute-induced AF, the platelet response was improved. Furthermore, a significant decrease of left atrium tissue factor-dependent procoagulant activity of MPs was observed. Acute episodes of AF results in a decrease in MPs-associated tissue factor activity, possibly corresponding to consumption, which in turn favors coagulation and the local production of thrombin. A decreased platelet basal aggregation to TRAP may result from PAR1 desensitization, whereas the improved response after an induced episode of AF suggests activation of coagulation and PAR1 re-sensitization.

1 January 2004 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
GCGisèle Clofent-Sanchez
Gisèle Clofent-Sanchez
CJCatherine Jais
Catherine Jais
EBEmilse Bermejo
Emilse Bermejo
LLLionel Leroux
Lionel Leroux
PCPierre Coste
Pierre Coste
PNPaquita Nurden
Paquita Nurden
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren Zeitschriftenartikeln

Verified
Journal Article
Open access
PDF file
KDKamel Deramchia
Kamel Deramchia
MJMarie-Josee Jacobin-Valat
Marie-Josee Jacobin-Valat
JLJeanny Laroche-Traineau
Jeanny Laroche-Traineau
SBStephane Bonetto
Stephane Bonetto
SSStephane Sanchez
Stephane Sanchez
GCGisèle Clofent-Sanchez
Gisèle Clofent-Sanchez
Atherosclerosis is a chronic, progressive inflammatory disease that may develop into vulnerable lesions leading to thrombosis. To interrogate the molecular components involved in this process, single-chain variable fragments (scFvs) from a semi-synthetic human antibody library were selected on the lesions induced in a rabbit model of atherosclerosis after two rounds of in vivo phage display. Homing Phage-scFvs were isolated from (1) the injured endothelium, (2) the underlying lesional tissue and (3) the cells within the intima. Clones selected on the basis of their redundancy or the presence of key amino acids, as determined by comparing the distribution between the native and the selected libraries, were produced in soluble form, and seven scFvs were shown to specifically target the endothelial cell surface and inflamed intima-related regions of rabbit tissue sections by immunohistology approaches. The staining patterns differed depending on the scFv compartment of origin. This study demonstrates that large-scale scFv binding assays can be replaced by a sequence-based selection of best clones, paving the way for easier use of antibody libraries in in vivo biopanning experiments. Future investigations will be aimed at characterizing the scFv/target couples by mass spectrometry to set the stage for more accurate diagnostic of atherosclerosis and development of therapeutic strategies.

24 November 2004 in Human Antibodies
Verified
Journal Article
Closed access
PDF file
MJMarie-Josée Jacobin
Marie-Josée Jacobin
XSXavier Santarelli
Xavier Santarelli
JLJeanny Laroche-Traineau
Jeanny Laroche-Traineau
GCGisèle Clofent-Sanchez
Gisèle Clofent-Sanchez
Purification of human IgM monoclonal antibodies (MAbs) has proved to be difficult. Since IgM Mabs tend to bind strongly to a variety of resin support surfaces, the number of chromatographic steps used in the purification of these biomolecules should